Advertisement

FortuneIndia

Quick Links :

Fortune 500 India
40 Under 40
Most Powerful Women
Budget 2024
India's Richest
The Next 500
Best B-Schools
Opinion
First Edit
Multimedia
Events

Fortune 500 India
40 Under 40
Most Powerful Women
The Next 500
Best B-Schools
All Rankings
Events
Macro
Enterprise
Technology
Reviews
Venture
Investing
Multimedia
Fortune India Exchange
Bystander
Opinion
Infographics
Ideas
Long Reads
People
Buy on Amazon
Polemicist
Annual Subscription

budesonide inhalation suspension

Share

November 2023

Aurobindo Pharma shares rise 2% on USFDA approval for asthma drug

Aurobindo Pharma shares rise 2% on USFDA approval for asthma drug

Aurobindo Pharma has received approval from USFDA to produce and trade Budesonide Inhalation Suspension

By Fortune India

Advertisement

Top Stories

Gold: No Letting Up

Gold: No Letting Up

SEBI mandates stress test results disclosure for all MFs

SEBI mandates stress test results disclosure for all MFs

MFs' share in NSE stocks hit fresh all-time high; FII-DII gap smallest ever

MFs' share in NSE stocks hit fresh all-time high; FII-DII gap smallest ever

Mahindra Q2 profit races 35% to ₹3,171 cr

Mahindra Q2 profit races 35% to ₹3,171 cr

Bitcoin tops $76,000 as Trump’s election win sparks bullish crypto wave

Bitcoin tops $76,000 as Trump’s election win sparks bullish crypto wave

Advertisement

Advertisement

Top Stories

Gold: No Letting Up

Gold: No Letting Up

SEBI mandates stress test results disclosure for all MFs

SEBI mandates stress test results disclosure for all MFs

MFs' share in NSE stocks hit fresh all-time high; FII-DII gap smallest ever

MFs' share in NSE stocks hit fresh all-time high; FII-DII gap smallest ever

Mahindra Q2 profit races 35% to ₹3,171 cr

Mahindra Q2 profit races 35% to ₹3,171 cr

Bitcoin tops $76,000 as Trump’s election win sparks bullish crypto wave

Bitcoin tops $76,000 as Trump’s election win sparks bullish crypto wave

Contact Us
Vision & Core Values
Terms of Use
Privacy & Cookie Policy